Mepolizumab - CaLiGraph

CaLiGraph

Property	Value
rdf:type	owl:NamedIndividual Immunosuppressant Monoclonal antibody Orphan drug Therapeutic monoclonal antibody Antiasthmatic drug GSK plc brand
rdfs:label	Mepolizumab
owl:sameAs	dbr:Mepolizumab
prov:wasDerivedFrom	http://en.wikipedia.org/wiki/Category:Orphan_drugs http://en.wikipedia.org/wiki/List_of_drugs:_Bi%E2%80%93Bo http://en.wikipedia.org/wiki/List_of_therapeutic_monoclonal_antibodies http://en.wikipedia.org/wiki/Category:Antiasthmatic_drugs http://en.wikipedia.org/wiki/Mast_cell_stabilizer http://en.wikipedia.org/wiki/Category:Immunosuppressants http://en.wikipedia.org/wiki/Category:Monoclonal_antibodies http://en.wikipedia.org/wiki/Monoclonal_antibody_therapy http://en.wikipedia.org/wiki/Asthma http://en.wikipedia.org/wiki/Desensitization_(medicine) http://en.wikipedia.org/wiki/Category:GSK_plc_brands http://en.wikipedia.org/wiki/Type_2_inflammation
skos:prefLabel	Mepolizumab
skos:altLabel	Bosatria antibodies directed against interleukin 5 mepolizumab
clgo:alternativeName	Nucala
clgo:bioavailability	80.0
clgo:casNumber	196078-29-2
clgo:drugbank	DB06612
clgo:fdaUniiCode	90Z2UF0E52
clgo:kegg	D04923
clgo:medlinePlus	a615058
is clgo:medication of	Eosinophilic granulomatosis with polyangiitis

About: clgr:Mepolizumab